Pephexia Therapeutics ApS — Credit Rating and Financial Key Figures
CVR number: 41319208
Nordre Fasanvej 215, 2000 Frederiksberg
kfo@pephexia.com
tel: 50910969
www.pephexia.com
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Purchases during the financial year | - 144.00 | ||||
| External services | - 147.00 | ||||
| Gross profit | - 291.00 | -4 738.04 | -5 266.26 | -3 212.13 | -2 085.44 |
| Employee benefit expenses | - 860.80 | -2 597.76 | -2 801.22 | -3 715.47 | |
| EBIT | - 291.00 | -5 598.84 | -7 864.02 | -6 013.35 | -5 800.91 |
| Other financial income | 2.47 | 21.56 | 7.41 | 8.82 | |
| Other financial expenses | -5.00 | - 116.71 | - 705.61 | - 965.74 | -1 029.23 |
| Pre-tax profit | - 296.00 | -5 713.08 | -8 548.06 | -6 971.68 | -6 821.31 |
| Income taxes | 54.00 | 1 180.76 | 1 870.60 | 1 531.94 | 1 500.44 |
| Net earnings | - 242.00 | -4 532.33 | -6 677.47 | -5 439.73 | -5 320.87 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Other receivables | 36.69 | 36.69 | |||
| Investments total | 36.69 | 36.69 | |||
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 54.00 | 1 182.10 | 1 870.58 | 1 560.48 | 1 575.32 |
| Prepayments and accrued income | 145.51 | 4.20 | |||
| Current other receivables | 28.00 | 101.19 | 1 083.30 | 1 037.03 | 437.78 |
| Short term receivables total | 82.00 | 1 283.29 | 3 099.39 | 2 601.72 | 2 013.09 |
| Cash and bank deposits | 706.00 | 3 528.85 | 6 647.01 | 2 613.07 | 3 843.73 |
| Cash and cash equivalents | 706.00 | 3 528.85 | 6 647.01 | 2 613.07 | 3 843.73 |
| Balance sheet total (assets) | 788.00 | 4 812.14 | 9 746.40 | 5 251.47 | 5 893.51 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 52.00 | 58.57 | 62.39 | 62.39 | 66.55 |
| Retained earnings | 872.00 | 1 821.69 | - 531.13 | -7 208.60 | -10 052.49 |
| Profit of the financial year | - 242.00 | -4 532.33 | -6 677.47 | -5 439.73 | -5 320.87 |
| Shareholders equity total | 682.00 | -2 652.07 | -7 146.21 | -12 585.94 | -15 306.81 |
| Non-current other liabilities | 7 089.53 | ||||
| Non-current deferred tax liabilities | 12 461.50 | 16 672.29 | 20 186.05 | ||
| Non-current liabilities total | 7 089.53 | 12 461.50 | 16 672.29 | 20 186.05 | |
| Current loans from credit institutions | 3 266.27 | ||||
| Current trade creditors | 26.00 | 269.14 | 511.14 | 230.73 | 513.91 |
| Current owed to participating | 79.00 | ||||
| Current owed to group member | 9.13 | 18.06 | |||
| Other non-interest bearing current liabilities | 1.00 | 105.53 | 184.76 | 334.74 | 244.52 |
| Accruals and deferred income | 459.80 | 581.60 | 255.84 | ||
| Current liabilities total | 106.00 | 374.67 | 4 431.11 | 1 165.13 | 1 014.27 |
| Balance sheet total (liabilities) | 788.00 | 4 812.14 | 9 746.40 | 5 251.47 | 5 893.51 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.